ARCHIVES

Senate Investigates Opioid Manufacturers, Requests Study of Impact of DEA Policies

This article is from The Cancer Letter archive.

Vol. 38 No. 19 | May 11, 2012

Download PDF Visit The Full Archive

Related Articles

Unclear Whether Clinical Trials Benefit Patients, Review Finds

February 27, 2004

In Brief: Former Oklahoma Re. Synar, Opponent of Tobacco, dead at 45 Of Brain Cancer

January 12, 1996

In Brief: Jane Henney Sworn In As FDA Commissioner; Six Centers Retain Comprehensive Status

December 18, 1998

Cooperative Groups: Insurers Agree To Cover Patient Care Costs In Group Trials

September 26, 1997

Steckel Urges AACI to seek Increase In Core Funding

July 17, 1981

House Republicans Move To Slash NIH Spending As Obama Calls For Renewed Investment in Science

February 18, 2011